Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99376
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99376
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99376
Figure 5 Proliferation and migration of KYSE150 cells after treatment with BIBR1532 combined with human telomerase reverse transcriptase overexpression.
A: Plate colony formation by KYSE150 cells after treatment with BIBR1532 (50 μM) and/or human telomerase reverse transcriptase (hTERT) overexpression for 48 hours; B: Migration evaluated by transwell assay of KYSE150 cells after treatment with BIBR1532 (50 μM) and/or hTERT overexpression for 48 hours; C: Migration evaluated by the scratch assay of KYSE150 cells after treatment with BIBR1532 (50 μM) and/or hTERT overexpression for 48 hours. hTERT: Human telomerase reverse transcriptase.
- Citation: Wang Q, Li QR, Xu L, Yuan ZC, Liu X, Tang MJ, Luo M, Zhong XW, Ma Q, Guo XL. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World J Gastrointest Oncol 2025; 17(1): 99376
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/99376.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.99376